Back to Stakeholders

Matt Mullenweg is tracked as an angel-capital stakeholder based on inclusion in the legacy psychedelic investor mapping list.

Investor Snapshot

Angel Investors

Classification

Angel Investor

Geography

Global

Coverage

Global

Last Verified

Apr 17, 2026

Investment Stage Focus

SeedSeries A-B

Investment Focus Areas

Drug Development

Investor Notes

Added from user-provided legacy investor list and retained with cross-tag-safe categorization. Explicit psychedelic relevance is captured from listed source evidence.

Verification

Unverified

Psychedelic Focus

No Public Psychedelic Focus

Engagement Status

Active

Primary Investment Link

Foundations & Philanthropy Snapshot

Grant-Making Organizations

Classification

Individual Donor / Family Office Giving

Geography

Global

Coverage

Global

Last Verified

Apr 10, 2026

Funding Focus Areas

Academic Research Funding

Support Types

Grant Funding

Verification

Unverified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Verification Notes

Public website is accessible, but this pass did not find sufficiently direct evidence of psychedelic-specific philanthropic grant activity.

Primary Funding Link

Quick Facts

Website
Visit